Probiotic shows promise for IBS and anxiety in new trial

NCT ID NCT07656623

Recruiting now Symptom relief Sponsor: Institute of Gastroenterology and Hepatology, Vietnam Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a probiotic called Ecologic Barrier to standard treatment helps adults with irritable bowel syndrome (IBS) who also have stomach issues and anxiety, depression, or stress. Sixty participants will receive either standard care or standard care plus the probiotic for two months. Researchers will track IBS severity, mood changes, and side effects over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ecologic Barrier (multispecies probiotic mixture)
What this could lead to: If it works, this could point toward a simple, safe supplement to reduce IBS symptoms and related anxiety or depression.
What could go wrong: This is a small, early-phase trial with only 60 people. The probiotic may not outperform standard treatment, and results may not apply to everyone with IBS.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME WITH DIARRHEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRRITABLE BOWEL SYNDROME WITH DIARRHEA

Contacts and locations

Locations

Institute of Gastroenterology and Hepatology
RECRUITING

Hanoi, Hanoi, 10000, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.